BMY vs BVS · P/E 17, rev $48.19B vs rev $285.3M
Bristol-Myers Squibb Company (BMY) versus Bioventus Inc (BVS) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Bioventus Inc (BVS) is a medical devices company listed on US.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported BVS revenue for 2026-06-27 was $285.3M. Net income was $36.6M. BVS currently screens at market cap $495.1M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. BVS currently screens at market cap $495.1M.
Not investment advice. Open the BMY and BVS stock pages for the full models.
Not investment advice.